CLTC(2-1634)insV-ALK(1059-1620) fusion [cytosol]

Stable Identifier
R-HSA-9710853
Type
Protein [EntityWithAccessionedSequence]
Species
Homo sapiens
Compartment
Synonyms
fullName evidence="36 37"Clathrin heavy chain 1, CLH1_HUMAN
Locations in the PathwayBrowser
Literature References
PubMed ID Title Journal Year
21494621 Inhibition of anaplastic lymphoma kinase (ALK) activity provides a therapeutic approach for CLTC-ALK-positive human diffuse large B cell lymphomas

Reiter, A, Siebert, R, Melnick, A, Pott, C, Damm-Welk, C, Yang, SN, Klapper, W, Harder, L, Vater, I, Woessmann, W, Cerchietti, L

PLoS One 2011
12920229 ALK+, CD30-, CD20- large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC)

Nagasawa, T, Kojima, H, Yamashita, Y, Mori, N, Shinagawa, A, Suzukawa, K, Ozawa, H, Chikatsu, N

Mod Pathol 2003
External Reference Information
External Reference
Gene Names
CLTC, CLH17, CLTCL2, KIAA0034
Chain
initiator methionine:, chain:2-1675
Participates
Other forms of this molecule
Modified Residues
Name
Insertion of residues 1059 to 1620 at 1635 from UniProt:Q9UM73 ALK
Coordinate
1635
Name
Replacement of residues 1634 to 1634 by YV
Disease
Cross References
COSMIC
Interactors (12)
Accession #Entities Entities Confidence Score Evidence (IntAct)
 UniProt:P32121 ARRB2  3 0.676 6
 UniProt:Q15398 DLGAP5  1 0.645 4
 UniProt:P13569 CFTR  17 0.615 21
 UniProt:P03372 ESR1  10 0.597 3
 UniProt:Q14164 IKBKE  5 0.589 2
 UniProt:P10636-8 MAPT  3 0.569 11
 UniProt:Q9NYZ3 GTSE1  4 0.564 3
 UniProt:Q13627 DYRK1A  1 0.547 2
 UniProt:O14920 IKBKB  3 0.536 2
 UniProt:Q96FJ0 STAMBPL1  1 0.527 2
 UniProt:P10242 MYB  1 0.499 4
 UniProt:P49407 ARRB1  6 0.491 3
Cite Us!